Scholar Rock Holding Corp (SRRK)
7.42
+0.35
(+4.95%)
USD |
NASDAQ |
Oct 04, 16:00
7.41
-0.01
(-0.13%)
After-Hours: 20:00
Scholar Rock Research and Development Expense (TTM): 150.76M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 150.76M |
| March 31, 2024 | 135.26M |
| December 31, 2023 | 121.90M |
| September 30, 2023 | 116.55M |
| June 30, 2023 | 119.61M |
| March 31, 2023 | 124.81M |
| December 31, 2022 | 124.44M |
| September 30, 2022 | 123.88M |
| June 30, 2022 | 121.76M |
| March 31, 2022 | 115.28M |
| December 31, 2021 | 108.47M |
| September 30, 2021 | 101.20M |
| June 30, 2021 | 88.32M |
| March 31, 2021 | 79.71M |
| Date | Value |
|---|---|
| December 31, 2020 | 74.06M |
| September 30, 2020 | 66.35M |
| June 30, 2020 | 63.66M |
| March 31, 2020 | 60.38M |
| December 31, 2019 | 54.22M |
| September 30, 2019 | 50.28M |
| June 30, 2019 | 42.64M |
| March 31, 2019 | 40.35M |
| December 31, 2018 | 36.31M |
| September 30, 2018 | 33.07M |
| June 30, 2018 | 29.79M |
| March 31, 2018 | 23.08M |
| December 31, 2017 | 19.94M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
54.22M
Minimum
Dec 2019
150.76M
Maximum
Jun 2024
102.66M
Average
115.28M
Median
Mar 2022
Research and Development Expense (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.043M |
| Palatin Technologies Inc | 22.40M |
| iBio Inc | 5.185M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 13.38M |